Company intelligence / Profile preview
DeepCure
Boston, Massachusetts, United Statesdeepcure.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
DeepCure’s lead candidate DC-9476—a selective Brd4 BD2 inhibitor—has shown superior efficacy to standard treatments in preclinical models of rheumatoid arthritis. The company has announced collaborations to further test this compound in RA patients. Additional pipeline programs are targeting STAT6 for asthma/atopic dermatitis and an undisclosed target for inflammatory diseases. No clinical trial results have been published yet; all programs appear to be preclinical or entering translational research phases
- Therapeutic areas
- PulmonologyDermatologyRheumatologyImmunology
- Modalities
- small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM) for translational studies in RA
Beyond the preview
Go deeper on DeepCure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DeepCure.